Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.

Wahl A, Ho PT, Denton PW, Garrett KL, Hudgens MG, Swartz G, O'Neill C, Veronese F, Kashuba AD, Garcia JV.

Sci Rep. 2017 Feb 1;7:41098. doi: 10.1038/srep41098.

2.

Analytical Advances in the Ex Vivo Challenge Efficacy Assay.

Richardson-Harman N, Parody R, Anton P, McGowan I, Doncel G, Thurman AR, Herrera C, Kordy K, Fox J, Tanner K, Swartz G, Dezzutti CS.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):395-403. doi: 10.1089/AID.2016.0073. Epub 2016 Dec 16.

3.

Evaluation of 2 Batched Pretreatment Systems for the Measurement of Whole Blood Tacrolimus on the ARCHITECT Immunoassay Analyzer.

Albeiroti S, Alberti MO, Buggs V, Swartz G, Butch AW, Drees JC, Kelly KA.

Lab Med. 2016 Nov;47(4):268-274. Epub 2016 Jul 29.

PMID:
27474776
4.

A randomised controlled trial of kinematically and mechanically aligned total knee replacements: two-year clinical results.

Dossett HG, Estrada NA, Swartz GJ, LeFevre GW, Kwasman BG.

Bone Joint J. 2014 Jul;96-B(7):907-13. doi: 10.1302/0301-620X.96B7.32812.

PMID:
24986944
5.

Evaluation of potential genotoxicity of HIV entry inhibitors derived from natural sources.

Paskaleva EE, Arra M, Liu Y, Guo H, Swartz G, Kennedy JS, Breneman C, Shekhtman A, Canki M.

PLoS One. 2014 Mar 25;9(3):e93108. doi: 10.1371/journal.pone.0093108. eCollection 2014.

6.

Kinematically versus mechanically aligned total knee arthroplasty.

Dossett HG, Swartz GJ, Estrada NA, LeFevre GW, Kwasman BG.

Orthopedics. 2012 Feb 17;35(2):e160-9. doi: 10.3928/01477447-20120123-04.

PMID:
22310400
7.

Synthesis of 2- and 17-substituted estrone analogs and their antiproliferative structure-activity relationships compared to 2-methoxyestradiol.

Shah JH, Agoston GE, Suwandi L, Hunsucker K, Pribluda V, Zhan XH, Swartz GM, LaVallee TM, Treston AM.

Bioorg Med Chem. 2009 Oct 15;17(20):7344-52. doi: 10.1016/j.bmc.2009.08.038. Epub 2009 Aug 21.

PMID:
19762246
8.

Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198.

LaVallee TM, Burke PA, Swartz GM, Hamel E, Agoston GE, Shah J, Suwandi L, Hanson AD, Fogler WE, Sidor CF, Treston AM.

Mol Cancer Ther. 2008 Jun;7(6):1472-82. doi: 10.1158/1535-7163.MCT-08-0107.

9.

Vesiculobullous disease.

Fox GN, Swartz GL, Mehregan DR.

J Fam Pract. 2005 Apr;54(4):355-6. No abstract available.

PMID:
15833227
10.
11.

Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity.

Hembrough TA, Ruiz JF, Swerdlow BM, Swartz GM, Hammers HJ, Zhang L, Plum SM, Williams MS, Strickland DK, Pribluda VS.

Blood. 2004 May 1;103(9):3374-80. Epub 2004 Jan 22.

12.

Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.

Hembrough TA, Swartz GM, Papathanassiu A, Vlasuk GP, Rote WE, Green SJ, Pribluda VS.

Cancer Res. 2003 Jun 1;63(11):2997-3000.

13.

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P.

Cancer Cell. 2003 Apr;3(4):363-75.

14.

2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway.

LaVallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ, Pribluda VS.

Cancer Res. 2003 Jan 15;63(2):468-75.

15.

Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.

Liu N, Lapcevich RK, Underhill CB, Han Z, Gao F, Swartz G, Plum SM, Zhang L, Green SJ.

Cancer Res. 2001 Feb 1;61(3):1022-8.

16.

2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.

Pribluda VS, Gubish ER Jr, Lavallee TM, Treston A, Swartz GM, Green SJ.

Cancer Metastasis Rev. 2000;19(1-2):173-9. Review.

PMID:
11191057
17.

Synthesis and enantiomeric separation of 2-phthalimidino-glutaric acid analogues: potent inhibitors of tumor metastasis.

Shah JH, Swartz GM, Papathanassiu AE, Treston AM, Fogler WE, Madsen JW, Green SJ.

J Med Chem. 1999 Aug 12;42(16):3014-7. No abstract available.

PMID:
10447943
18.

Interaction of anti-cholesterol antibodies with human lipoproteins.

Dijkstra J, Swartz GM Jr, Raney JJ, Aniagolu J, Toro L, Nacy CA, Green SJ.

J Immunol. 1996 Sep 1;157(5):2006-13.

PMID:
8757321
19.

Role of atheroma liposomes and malondialdehyde-modified low-density lipoproteins in complement activation.

Sorace JM, Rollins S, Aniagolu JU, Mergner WJ, Cole K, Swartz GM Jr, Green SJ.

Pathobiology. 1996;64(2):73-8.

PMID:
8888272
20.

Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation.

Alving CR, Swartz GM Jr, Wassef NM, Ribas JL, Herderick EE, Virmani R, Kolodgie FD, Matyas GR, Cornhill JF.

J Lab Clin Med. 1996 Jan;127(1):40-9.

PMID:
8592095
21.

Analysis of anticholesterol antibodies using hydrophobic membranes.

Aniagolu J, Swartz GM Jr, Dijkstra J, Madsen JW, Raney JJ, Green SJ.

J Immunol Methods. 1995 May 11;182(1):85-92.

PMID:
7769249
22.

Liposomal vaccines.

Green S, Fortier A, Dijkstra J, Madsen J, Swartz G, Einck L, Gubish E, Nacy C.

Adv Exp Med Biol. 1995;383:83-92. Review.

PMID:
8644517
23.

ATP specifically bound as a hapten to a monoclonal anti-phospholipid antibody retains phosphate donor activity.

Wassef NM, Swartz GM, Alving BM, Alving CR.

Biochem Biophys Res Commun. 1993 Jan 29;190(2):582-8.

PMID:
8381281
24.
25.

Antibodies to liposomal phosphatidylcholine and phosphatidylsulfocholine.

Wassef NM, Swartz GM Jr, Alving CR, Kates M.

Biochem Cell Biol. 1990 Jan;68(1):54-8.

PMID:
2190620
26.

Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A.

Richards RL, Swartz GM Jr, Schultz C, Hayre MD, Ward GS, Ballou WR, Chulay JD, Hockmeyer WT, Berman SL, Alving CR.

Vaccine. 1989 Dec;7(6):506-12.

PMID:
2692333
27.

Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs.

Wassef NM, Johnson SH, Graeber GM, Swartz GM Jr, Schultz CL, Hailey JR, Johnson AJ, Taylor DG, Ridgway RL, Alving CR.

J Immunol. 1989 Nov 1;143(9):2990-5.

PMID:
2809213
28.

Naturally occurring autoantibodies to cholesterol in humans.

Alving CR, Swartz GM Jr, Wassef NM.

Biochem Soc Trans. 1989 Aug;17(4):637-9. No abstract available.

PMID:
2767325
29.

Cross-reactions of nucleic acids with monoclonal antibodies to phosphatidylinositol phosphate and cholesterol.

Stollar BD, McInerney T, Gavron T, Wassef NM, Swartz GM Jr, Alving CR.

Mol Immunol. 1989 Jan;26(1):73-9.

PMID:
2538726
31.

Antibodies to cholesterol.

Swartz GM Jr, Gentry MK, Amende LM, Blanchette-Mackie EJ, Alving CR.

Proc Natl Acad Sci U S A. 1988 Mar;85(6):1902-6.

32.

Antibodies to phospholipids and liposomes: binding of antibodies to cells.

Fogler WE, Swartz GM Jr, Alving CR.

Biochim Biophys Acta. 1987 Oct 2;903(2):265-72.

PMID:
2820489
33.
34.

Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice.

Kende M, Alving CR, Rill WL, Swartz GM Jr, Canonico PG.

Antimicrob Agents Chemother. 1985 Jun;27(6):903-7.

35.

Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.

Gilbreath MJ, Nacy CA, Hoover DL, Alving CR, Swartz GM Jr, Meltzer MS.

J Immunol. 1985 May;134(5):3420-5.

PMID:
3980997
36.

Differential inhibition of macrophage microbicidal activity by liposomes.

Gilbreath MJ, Swartz GM Jr, Alving CR, Nacy CA, Hoover DL, Meltzer MS.

Infect Immun. 1985 Feb;47(2):567-9.

37.

Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes.

Wassef NM, Roerdink F, Swartz GM Jr, Lyon JA, Berson BJ, Alving CR.

Mol Immunol. 1984 Oct;21(10):863-8.

PMID:
6095072
38.

Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters.

Alving CR, Swartz GM Jr, Hendricks LD, Chapman WL Jr, Waits VB, Hanson WL.

Ann Trop Med Parasitol. 1984 Jun;78(3):279-86.

PMID:
6486933
39.

Consider a safety audit program.

Swartz G.

Prof Saf. 1983 Apr;28(4):47-9. No abstract available.

PMID:
10259242
40.

Lack of effect of nonsteroidal anti-inflammatory drugs on exercise-induced hyperkalemia.

Saris S, Lowenthal DT, Affrime MB, Rosenthal L, Swartz G.

N Engl J Med. 1982 Aug 26;307(9):559-60. No abstract available.

PMID:
7048098
41.

Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline.

Alving CR, Steck EA, Chapman WL Jr, Waits VB, Hendricks LD, Swartz GM Jr, Hanson WL.

Life Sci. 1980 Jun 30;26(26):2231-8. No abstract available.

PMID:
7401920
42.

Sporozoite-induced malaria: therapeutic effects of glycolipids in liposomes.

Alving CR, Schneider I, Swartz GM Jr, Steck EA.

Science. 1979 Sep 14;205(4411):1142-4.

PMID:
382358
43.

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

Alving CR, Steck EA, Chapman WL Jr, Waits VB, Hendricks LD, Swartz GM Jr, Hanson WL.

Proc Natl Acad Sci U S A. 1978 Jun;75(6):2959-63.

44.

Benign chondroblastoma of talus demonstrated by skeletal scanning.

Ulreich S, Swartz G, Stier SA, Philips E.

Clin Nucl Med. 1978 Feb;3(2):62-3.

PMID:
657655
45.

Hamster ultimobranchial bodies: histochemical study during development.

Howk DJ, Swartz GE.

Trans Am Microsc Soc. 1970 Jul;89(3):355-67. No abstract available.

PMID:
5529975
46.

The ultimobranchial body of the chick embryo.

Nagy F, Swartz GE.

Trans Am Microsc Soc. 1966 Oct;85(4):485-505. No abstract available.

PMID:
4166986
47.

OBSERVATIONS ON THE ULTIMOBRANCHIAL BODY IN RANA PIPIENS.

ROBERTSON DR, SWARTZ GE.

Anat Rec. 1964 Feb;148:219-29. No abstract available.

PMID:
14123506
48.

Study of macular degeneration and lipid metabolism; preliminary report.

SWARTZ G, HAGUE EB.

Bull Millard Fillmore Hosp Buffalo. 1961;8:52-6. No abstract available.

PMID:
13774239
49.

Keratoplasty for keratoconus.

PATON RT, SWARTZ G.

AMA Arch Ophthalmol. 1959 Mar;61(3):370-2. No abstract available.

PMID:
13626298
50.

Keratoplasty for Fuchs' dystrophy.

PATON RT, SWARTZ G.

AMA Arch Ophthalmol. 1959 Mar;61(3):366-9. No abstract available.

PMID:
13626297

Supplemental Content

Loading ...
Support Center